BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7387137)

  • 1. Evaluation of slow infusions of co-trimoxazole by using predictive pharmacokinetics.
    Morgan DJ; Raymond K
    Antimicrob Agents Chemother; 1980 Feb; 17(2):132-7. PubMed ID: 7387137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pharmacokinetics and in vitro bactericidal activity of trimethoprim-sulfamethoxazole.
    Spicehandler J; Pollock AA; Simberkoff MS; Rahal JJ
    Rev Infect Dis; 1982; 4(2):562-5. PubMed ID: 6981172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of intravenously administered trimethoprim-sulfamethoxazole.
    Grose WE; Bodey GP; Loo TL
    Antimicrob Agents Chemother; 1979 Mar; 15(3):447-51. PubMed ID: 464572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.
    Kaplan SA; Weinfeld RE; Abruzzo CW; McFaden K; Jack ML; Weissman L
    J Infect Dis; 1973 Nov; 128():Suppl:547-55 p. PubMed ID: 4758045
    [No Abstract]   [Full Text] [Related]  

  • 6. Single and multiple dose kinetics of co-tetroxazine and co-trimoxazole in patients.
    Vergin H; Ferber H; Zimmermann I; Neurath GB
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):350-7. PubMed ID: 6975762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses.
    Kremers P; Duvivier J; Heusghem C
    J Clin Pharmacol; 1974; 14(2):112-7. PubMed ID: 4813080
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacokinetics of sulphadiazine and sulphamethoxazole after intravenous infusion.
    Männistö PT; Mäntylä R; Mattila J; Nykänen S; Lamminsivu U
    J Antimicrob Chemother; 1982 Jun; 9(6):461-70. PubMed ID: 6980876
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.
    Bach MC; Gold O; Finland M
    J Infect Dis; 1973 Nov; 128():Suppl:584-99 p. PubMed ID: 4758050
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).
    Patel RB; Welling PG
    Clin Pharmacokinet; 1980; 5(5):405-23. PubMed ID: 7408366
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of co-trimoxazole and co-tetroxazine in geriatric patients.
    Naber K; Vergin H; Weigand W
    Infection; 1981; 9(5):239-43. PubMed ID: 6975241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure.
    Welling PG; Craig WA; Amidon GL; Kunin CM
    J Infect Dis; 1973 Nov; 128():Suppl:556-66 p. PubMed ID: 4758046
    [No Abstract]   [Full Text] [Related]  

  • 15. The Pharmacokinetic profile of co-trimoxazole.
    Bergan T; Brodwall EK
    Scand J Infect Dis Suppl; 1976; (8):42-9. PubMed ID: 1064911
    [No Abstract]   [Full Text] [Related]  

  • 16. Trimethoprim-sulfonamide combination administered orally and intravaginally in the first trimester of pregnancy: its absorption into serum and transfer to amniotic fluid.
    Ylikorkala O; Sjöstedt E; Järvinen PA; Tikkanen R; Raines T
    Acta Obstet Gynecol Scand; 1973; 52(3):229-34. PubMed ID: 4743777
    [No Abstract]   [Full Text] [Related]  

  • 17. Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination.
    Reid DW; Caille G; Kaufmann NR
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):67-72. PubMed ID: 1137830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous sulfamethoxazole-trimethoprim: pharmacokinetics, therapeutic indications, and adverse reactions.
    Gleckman R; Gantz NM; Joubert DW
    Pharmacotherapy; 1981; 1(3):206-11. PubMed ID: 6985449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacology of co-trimoxazole (biseptol)].
    Klimowicz A
    Postepy Hig Med Dosw; 1983; 37(5-6):537-60. PubMed ID: 6387682
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
    Wright WL; Larking P; Lovell-Smith CJ
    Br J Urol; 1982 Oct; 54(5):550-1. PubMed ID: 6983378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.